Literature DB >> 29022957

Clinical Patterns and risk factors for rhegmatogenous retinal detachment at a tertiary eye care centre of northern India.

Brijesh Takkar, Shorya Azad, Indrish Bhatia, Rajvardhan Azad.   

Abstract

PURPOSE: To identify patterns and risk factors for rhegmatogenous retinal detachment (RD) in northern India.
METHODS: This was a retrospective study conducted at a tertiary care centre in northern India. 378 consecutive records of patient, operated between January 2011 to June 2012 were included for analysis. Clinical history, signs and risk factors of RD were evaluated. Comparison was done with available literature from other developing nations.
RESULTS: Mean age of the patients was 40.12 + 20.43 years (Range 12-85 years); 81% were male and half of the patients presented after 1 month of visual symptoms. Retinal breaks were discovered commonly in the temporal region, while no break was found in10% of the patients. PVR more than grade C was seen in a third of the patients. Prior surgery for cataract was found to be the most common identifiable risk factor for RD (40%). Bilateral RD was seen in 13% of the patients.
CONCLUSION: Pseudophakia is the commonest risk factor for RD. If no retinal break is discovered pre operatively, the surgeon should seek a retinal break temporally during surgery. Bilateral RD is a serious concern for rural northern India, probably linked to delayed presentation. © NEPjOPH.

Entities:  

Mesh:

Year:  2017        PMID: 29022957     DOI: 10.3126/nepjoph.v9i1.17536

Source DB:  PubMed          Journal:  Nepal J Ophthalmol        ISSN: 2072-6805


  2 in total

1.  Vitreoretinal Surgery amid Coronavirus Disease 2019 Pandemic Restrictions.

Authors:  Cagri Ilhan; Mehmet Citirik; Mehmet Yasin Teke
Journal:  J Curr Ophthalmol       Date:  2021-10-22

2.  Observer variation in quantitative assessment of retinal shortening with ultrasound in patients of total rhegmatogenous retinal detachment.

Authors:  Brijesh Takkar; Nripen Gaur; Hameed Obedulla; Ramesh Chand Chauhan; Shreyas Temkar; Pradeep Venkatesh; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.